To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZYXTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
378 representative clones for gene ZYX back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_003461.4   .a 1 to 2304 1 to 2304 exact RefSeq, AAA   2304/2304
(100 %)
0 diff
(100 %id)
BM857080 stomach .a 8 to 352 1 to 345   tiling clone,   345/345
(100 %)
0 diff
(100 %id)
BC008743 Skin, melanotic melanoma. .a 37 to 2304 1 to 2268   tiling clone, available from MGC, AAA   2268/2268
(100 %)
0 diff
(100 %id)
CT001657 T-Lymphocytes .a 41 to 536 1 to 496       496/497
(99 %)
1 diff
(99.8 %id)
AL583670 T cells (Jurkat cell line), T cells from T cell leukemia .a 43 to 1099 1 to 1050       1050/1050
(100 %)
35 diff
(96.7 %id)
CR987323 T-Lymphocytes .a 44 to 533 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BM151755 leukopheresis .a 51 to 237 1 to 184       184/196
(93 %)
20 diff
(89.8 %id)
TI_57173307   .a 56 to 472 22 to 439       418/441
(94 %)
13 diff
(97.1 %id)
TI_57234930   .a 57 to 454 32 to 441       410/464
(88 %)
15 diff
(96.8 %id)
CR989186 T-Lymphocytes .a 59 to 425 1 to 367       367/368
(99 %)
1 diff
(99.8 %id)
TI_57196696   .a 68 to 415 62 to 416       355/416
(85 %)
26 diff
(93.8 %id)
BU517206 leiomyosarcoma, uterus .a 76 to 885 1 to 818       818/902
(90 %)
16 diff
(98.3 %id)
BM147577 leukopheresis .a 78 to 453 1 to 376       376/376
(100 %)
8 diff
(97.9 %id)
BM857018 stomach .a 79 to 429 1 to 351       351/351
(100 %)
0 diff
(100 %id)
BM848285 myeloma .a 81 to 337 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BM149766 leukopheresis .a 81 to 675 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
BM150262 leukopheresis .a 81 to 693 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
TI_57197252   .a 87 to 441 31 to 391       361/391
(92 %)
13 diff
(96.7 %id)
BU521034 leiomyosarcoma, uterus .a 88 to 894 5 to 822       818/878
(93 %)
32 diff
(96.4 %id)
X95735 placenta .a 88 to 2304 1 to 2217       2217/2217
(100 %)
0 diff
(100 %id)
TI_57198363   .a 89 to 467 30 to 418       387/419
(92 %)
21 diff
(95.0 %id)
TI_57232620   .a 90 to 423 22 to 354       333/511
(65 %)
10 diff
(98.1 %id)
TI_57234874   .a 90 to 475 36 to 434       399/438
(91 %)
28 diff
(93.7 %id)
TI_159676789   .a 96 to 582 103 to 594       492/1005
(48 %)
42 diff
(95.9 %id)
TI_57166527   .a 98 to 681 68 to 657       587/658
(89 %)
31 diff
(95.3 %id)
BC010031 Kidney, renal cell adenocarcinoma .a 104 to 2304 1 to 2201   available from MGC, AAA   2201/2201
(100 %)
1 diff
(100.0 %id)
AL579250 T cells (Jurkat cell line), T cells from T cell leukemia .a 1291 to 2196 905 to 1       905/1009
(89 %)
22 diff
(97.9 %id)
NM_001010972.1   .b 1 to 2301 1 to 2301 exact RefSeq, AAA   2301/2301
(100 %)
0 diff
(100 %id)
CT004871 T-Lymphocytes .b 36 to 528 1 to 493   tiling clone,   493/493
(100 %)
0 diff
(100 %id)
AL583574 brain, fetal brain .b 43 to 1068 1 to 1019       1019/1048
(97 %)
20 diff
(98.1 %id)
AL547011 placenta, Placenta Cot 25-normalized .b 44 to 1008 1 to 964       964/964
(100 %)
14 diff
(98.6 %id)
AL556892 placenta .b 44 to 1051 1 to 1010       1010/1014
(99 %)
5 diff
(99.6 %id)
BU192001 large cell carcinoma, lung .b 44 to 806 1 to 769       769/900
(85 %)
22 diff
(97.6 %id)
BQ949322 large cell carcinoma, lung .b 48 to 922 23 to 907       885/955
(92 %)
34 diff
(96.5 %id)
AL521996 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 50 to 917 1 to 866       866/866
(100 %)
3 diff
(99.7 %id)
BX365832 Neuroblastoma Cot 10-normalized .b 50 to 801 1 to 750       750/750
(100 %)
4 diff
(99.5 %id)
BQ954342 large cell carcinoma, lung .b 54 to 958 1 to 930       930/941
(98 %)
41 diff
(95.7 %id)
BX341801   .b 56 to 921 1 to 866       866/991
(87 %)
23 diff
(97.7 %id)
CN276982 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 85 to 434 1 to 350       350/350
(100 %)
0 diff
(100 %id)
CR981654 T-Lymphocytes .b 88 to 528 1 to 441       441/441
(100 %)
0 diff
(100 %id)
BC009360 Uterus, leiomyosarcoma .b 89 to 2301 1 to 2213   available from MGC, AAA   2213/2213
(100 %)
1 diff
(100.0 %id)
BX458834 placenta .b 89 to 1097 24 to 1019       996/1047
(95 %)
28 diff
(97.4 %id)
BQ923496 eye, normal pigmented retinal epithelium .b 89 to 886 1 to 805       805/998
(80 %)
24 diff
(97.6 %id)
BX460803 brain, fetal brain .b 93 to 1000 23 to 930       908/930
(97 %)
11 diff
(98.9 %id)
BX463957 brain, fetal brain .b 93 to 1087 23 to 994       972/1016
(95 %)
34 diff
(96.7 %id)
BM920195 pooled pancreas and spleen .b 96 to 840 1 to 751       751/1115
(67 %)
21 diff
(98.2 %id)
AL549126 placenta, Placenta Cot 25-normalized .b 99 to 1050 1 to 944       919/950
(96 %)
46 diff
(95.2 %id)
CR974710 T-Lymphocytes .b 102 to 532 1 to 431       431/432
(99 %)
1 diff
(99.8 %id)
AL554237 placenta, Placenta Cot 25-normalized .b 104 to 1141 1 to 1029       1029/1031
(99 %)
26 diff
(97.5 %id)
CN276975 embryonic stem cells, cell lines H1, H7, andH9 .b 115 to 374 1 to 260       260/260
(100 %)
0 diff
(100 %id)
CR994300 T-Lymphocytes .b 119 to 527 1 to 409       409/409
(100 %)
0 diff
(100 %id)
X94991 umbilical vein .b 146 to 2299 1 to 2154   AAA   2154/2154
(100 %)
1 diff
(100.0 %id)
AL548984 placenta, Placenta Cot 25-normalized .b 149 to 1148 1 to 994       994/994
(100 %)
10 diff
(99.0 %id)
TI_1948154708   .b 155 to 1045 124 to 1012   fully sequenced,   889/1012
(87 %)
18 diff
(98.3 %id)
TI_1948154867   .b 155 to 1070 123 to 1039       917/1330
(68 %)
64 diff
(95.2 %id)
CR457431   .b 156 to 1870 1 to 1715       1715/1719
(99 %)
1 diff
(100.0 %id)
DA147148 amygdala .b 160 to 745 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA548140   .b 160 to 673 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA589226 lung .b 161 to 726 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA678430   .b 161 to 694 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA716660   .b 161 to 678 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DA879321 Prostate .b 161 to 750 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA600218   .b 162 to 725 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA059207 cerebellum .b 186 to 636 2 to 452   capped   451/451
(100 %)
0 diff
(100 %id)
DA593865 lung .b 188 to 761 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BM835378 stomach .b 188 to 522 1 to 335       335/335
(100 %)
0 diff
(100 %id)
AK302309 testis .b 190 to 1973 1 to 1784       1784/1784
(100 %)
2 diff
(99.9 %id)
BQ953096 eye, normal pigmented retinal epithelium .b 190 to 1009 1 to 827       827/952
(86 %)
10 diff
(99.0 %id)
DB249671 uterus .b 192 to 692 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA478082   .b 193 to 735 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA478104   .b 193 to 748 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA050752   .b 194 to 773 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CN482158 eye .b 198 to 709 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BQ948112 epidermoid carcinoma, cell line, lung .b 210 to 1052 1 to 853       853/863
(98 %)
17 diff
(98.1 %id)
DA819058   .b 212 to 749 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB104385 thymus .b 214 to 769 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM424144 amelanotic melanoma, cell line, skin .b 216 to 1107 20 to 926       907/1004
(90 %)
36 diff
(96.5 %id)
DB195298 trachea .b 216 to 738 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
BM423653 amelanotic melanoma, cell line, skin .b 224 to 1125 10 to 925       916/1045
(87 %)
44 diff
(95.8 %id)
BM911898 amelanotic melanoma, cell line, skin .b 225 to 1096 1 to 880       880/999
(88 %)
40 diff
(96.0 %id)
AL552048 placenta, Placenta Cot 25-normalized .b 231 to 1102 1 to 867       867/869
(99 %)
14 diff
(98.4 %id)
BQ953043 eye, normal pigmented retinal epithelium .b 231 to 1015 1 to 791       791/972
(81 %)
13 diff
(98.7 %id)
DA882329   .b 232 to 779 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA883442   .b 232 to 805 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB266602 uterus .b 235 to 660 2 to 427   capped   426/426
(100 %)
0 diff
(100 %id)
AL554730 placenta, Placenta Cot 25-normalized .b 246 to 1216 1 to 965   fully sequenced,   965/965
(100 %)
13 diff
(98.7 %id)
AL521726 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 249 to 1122 1 to 873       873/873
(100 %)
4 diff
(99.6 %id)
BC006532 Placenta, choriocarcinoma .b 263 to 2301 1804 to 3842   tiling clone, AAA   2039/3842
(53 %)
6 diff
(99.9 %id)
DA885069   .b 304 to 850 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
U15158 epididymis .b 393 to 2301 1 to 1908       1908/1908
(100 %)
3 diff
(99.9 %id)
AL554147 placenta, Placenta Cot 25-normalized .b 396 to 1232 1 to 832       832/870
(95 %)
20 diff
(97.8 %id)
AA477057 ovarian tumor, ovary .b 559 to 1071 4 to 513       510/513
(99 %)
8 diff
(98.5 %id)
BM718644 eye, fetal eye .b 826 to 1476 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BG748696 eye, normal pigmented retinal epithelium .b 991 to 1851 1 to 860       858/861
(99 %)
6 diff
(99.4 %id)
CX784823 human embryonic stem cells .b 1013 to 1911 1 to 899       899/899
(100 %)
1 diff
(99.9 %id)
TI_1948154709   .b 1015 to 1873 989 to 130   fully sequenced,   860/989
(86 %)
5 diff
(99.5 %id)
BG675171 skin .b 1046 to 1818 1 to 774       774/774
(100 %)
4 diff
(99.5 %id)
AA218697 brain, neuroepithelial cells .b 1053 to 1426 1 to 371       371/371
(100 %)
10 diff
(97.4 %id)
BG576822 breast, mammary adenocarcinoma, cell line .b 1070 to 1804 7 to 741       735/742
(99 %)
16 diff
(97.9 %id)
TI_1948154868   .b 1074 to 1873 925 to 125       801/1295
(61 %)
5 diff
(99.7 %id)
CN276986 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1102 to 1822 1 to 721       721/721
(100 %)
2 diff
(99.8 %id)
BG179070 adenocarcinoma, cell line, Prostate .b 1115 to 1838 1 to 733       733/1139
(64 %)
30 diff
(97.4 %id)
AU123746   .b 1124 to 1949 2 to 830   capped   829/833
(99 %)
14 diff
(98.4 %id)
BM906264 ovary (pool of 3) .b 1125 to 2126 20 to 1027       1008/1071
(94 %)
40 diff
(96.3 %id)
BI083981 epidermoid carcinoma, cell line, salivary gland .b 1128 to 1724 1 to 597   fully sequenced,   597/597
(100 %)
5 diff
(99.2 %id)
BQ928274 carcinoma, cell line, Prostate .b 1169 to 1925 13 to 767       755/984
(76 %)
20 diff
(98.0 %id)
BQ919315 carcinoma, cell line, Prostate .b 1172 to 2032 1 to 870       870/938
(92 %)
9 diff
(99.1 %id)
BQ937239 carcinoma, cell line, Prostate .b 1172 to 2006 1 to 853       853/866
(98 %)
24 diff
(97.3 %id)
BU552619 carcinoma, cell line, Prostate .b 1172 to 2046 1 to 886       886/921
(96 %)
18 diff
(98.1 %id)
BI911014 leukocyte .b 1176 to 1946 8 to 774       767/777
(98 %)
14 diff
(98.2 %id)
BM044655 carcinoma, cell line, Prostate .b 1176 to 1955 9 to 788       780/876
(89 %)
18 diff
(98.0 %id)
TI_57236414   .b 1176 to 1946 44 to 810       767/813
(94 %)
14 diff
(98.3 %id)
AL577369 placenta, Placenta Cot 25-normalized .b 1186 to 2242 1052 to 1   fully sequenced,   1052/1052
(100 %)
32 diff
(97.0 %id)
AL568246 brain, fetal brain .b 1188 to 2223 1079 to 46       1034/1079
(95 %)
15 diff
(98.7 %id)
BI114027 muscle, rhabdomyosarcoma .b 1188 to 1978 1 to 790       790/794
(99 %)
19 diff
(97.7 %id)
AL577001 placenta, Placenta Cot 25-normalized .b 1197 to 2251 1051 to 9       1043/1053
(99 %)
33 diff
(96.9 %id)
CR983456 T-Lymphocytes .b 1201 to 2050 1 to 853       853/853
(100 %)
6 diff
(99.3 %id)
BG911897 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1225 to 1960 1 to 739       739/740
(99 %)
14 diff
(98.2 %id)
BM802325 duodenal adenocarcinoma, cell line, small intestine .b 1231 to 2137 1 to 917       917/939
(97 %)
21 diff
(97.8 %id)
AL573347 placenta, Placenta Cot 25-normalized .b 1233 to 2269 1036 to 1       1036/1040
(99 %)
7 diff
(99.4 %id)
BI760919 pooled colon, kidney, stomach .b 1239 to 2053 1 to 808       808/809
(99 %)
11 diff
(98.7 %id)
TI_57146423   .b 1239 to 2053 35 to 842       808/843
(95 %)
17 diff
(98.0 %id)
BU182647 melanotic melanoma, skin .b 1240 to 2166 1 to 938       938/940
(99 %)
17 diff
(98.2 %id)
TI_227712428   .b 1292 to 2301 1084 to 86   AAA   999/1039
(96 %)
21 diff
(98.0 %id)
BF972419 leiomyosarcoma cell line, uterus .b 1296 to 2127 1 to 823       823/901
(91 %)
36 diff
(96.1 %id)
AL579013 placenta .b 1297 to 2273 967 to 1       967/1025
(94 %)
14 diff
(98.7 %id)
AL572130 placenta, Placenta Cot 25-normalized .b 1300 to 2273 973 to 1       973/973
(100 %)
14 diff
(98.6 %id)
AL575571 placenta, Placenta Cot 25-normalized .b 1311 to 2273 961 to 1       961/961
(100 %)
8 diff
(99.2 %id)
BE868042 adenocarcinoma, colon .b 1313 to 2141 1 to 810       810/973
(83 %)
43 diff
(95.6 %id)
BG751377 eye, normal pigmented retinal epithelium .b 1317 to 2181 1 to 857       857/858
(99 %)
22 diff
(97.5 %id)
TI_227716975   .b 1317 to 2301 1060 to 93   AAA   968/1027
(94 %)
30 diff
(97.1 %id)
BX463956 brain, fetal brain .b 1321 to 2274 945 to 1       945/962
(98 %)
15 diff
(98.5 %id)
AL573445 placenta, Placenta Cot 25-normalized .b 1324 to 2248 943 to 23       921/955
(96 %)
24 diff
(97.5 %id)
AL576947 placenta, Placenta Cot 25-normalized .b 1324 to 2246 918 to 1       918/938
(97 %)
20 diff
(97.9 %id)
BM691452 eye, RPE and Choroid .b 1351 to 1849 7 to 505   fully sequenced,   499/505
(98 %)
0 diff
(100 %id)
AL562018 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1359 to 2275 909 to 1       909/909
(100 %)
11 diff
(98.8 %id)
BG032707 breast, mammary adenocarcinoma, cell line .b 1382 to 2125 1 to 731       731/966
(75 %)
24 diff
(97.6 %id)
BM009889 amelanotic melanoma, cell line, skin .b 1393 to 2181 1 to 784       784/784
(100 %)
12 diff
(98.5 %id)
TI_59384669   .b 1394 to 2181 59 to 841       783/783
(100 %)
11 diff
(98.6 %id)
TI_227712439   .b 1403 to 2301 967 to 86   AAA   882/986
(89 %)
17 diff
(98.3 %id)
BM129245 Islets of Langerhans, Pancreas .b 1407 to 1800 1 to 393   fully sequenced,   393/393
(100 %)
6 diff
(98.5 %id)
BM129731 Islets of Langerhans, Pancreas .b 1407 to 1877 1 to 471   fully sequenced,   471/471
(100 %)
0 diff
(100 %id)
BU929229 placenta .b 1408 to 2205 1 to 800       800/804
(99 %)
7 diff
(99.2 %id)
BG330517 large cell carcinoma, lung .b 1443 to 2222 1 to 761       761/950
(80 %)
30 diff
(96.9 %id)
TI_154062165   .b 1462 to 2301 928 to 95   AAA   834/991
(84 %)
15 diff
(98.5 %id)
TI_227717014   .b 1462 to 2301 916 to 89   AAA   828/991
(83 %)
16 diff
(98.4 %id)
BQ064769 lymph, lymphoma, cell line .b 1463 to 2301 1 to 851       851/977
(87 %)
13 diff
(98.7 %id)
TI_227714355   .b 1470 to 2301 909 to 86   AAA   824/968
(85 %)
10 diff
(99.0 %id)
BU150179 ductal carcinoma, cell line, Pancreas .b 1492 to 2301 838 to 23   AAA Submitted on the opposite strand 816/899
(90 %)
25 diff
(97.3 %id)
TI_154102052   .b 1493 to 2301 858 to 58   AAA   801/917
(87 %)
14 diff
(98.5 %id)
BM008467 Spleen .b 1503 to 2309 1 to 806       806/823
(97 %)
22 diff
(97.4 %id)
TI_59383200   .b 1504 to 2309 104 to 908       805/935
(86 %)
21 diff
(97.8 %id)
BF975404 B-cells, primary B-cells from tonsils (cell line) .b 1507 to 2271 1 to 769       769/769
(100 %)
9 diff
(98.9 %id)
TI_154101194   .b 1507 to 2301 874 to 85   AAA   790/791
(99 %)
5 diff
(99.4 %id)
BU162917 ductal carcinoma, cell line, Pancreas .b 1508 to 2301 826 to 23   AAA Submitted on the opposite strand 804/1009
(79 %)
37 diff
(96.4 %id)
BU507272 leiomyosarcoma, uterus .b 1509 to 2303 1 to 817   AAA   817/839
(97 %)
28 diff
(96.7 %id)
BF527407 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1513 to 2271 1 to 758       758/810
(93 %)
16 diff
(98.1 %id)
BU188721 adenocarcinoma, Pancreas .b 1523 to 2297 1 to 785       785/954
(82 %)
27 diff
(97.2 %id)
CD367134 Alveolar Macrophage, lung .b 1539 to 2301 779 to 17   AAA   763/763
(100 %)
3 diff
(99.7 %id)
BQ787910 insulinoma, Pancreas .b 1559 to 2061 8 to 510   fully sequenced,   503/510
(98 %)
0 diff
(100 %id)
TI_149314879   .b 1565 to 2301 819 to 87   AAA   733/947
(77 %)
17 diff
(98.3 %id)
BM665378 eye, Retina Foveal and Macular .b 1611 to 2298 706 to 19   AAA   688/697
(98 %)
4 diff
(99.5 %id)
BU734011 eye, Retina Foveal and Macular .b 1611 to 2298 706 to 19   AAA   688/696
(98 %)
4 diff
(99.5 %id)
CD364366 Alveolar Macrophage, lung .b 1611 to 2301 707 to 17   AAA   691/691
(100 %)
0 diff
(100 %id)
BU625468 cell lines, Enchondroma .b 1616 to 2301 704 to 19   AAA   686/686
(100 %)
0 diff
(100 %id)
BM692708 eye, Retina Foveal and Macular .b 1618 to 2172 1 to 555       555/555
(100 %)
0 diff
(100 %id)
CB529447 Aveolar Macrophage, lung .b 1618 to 2301 700 to 17   AAA   684/684
(100 %)
0 diff
(100 %id)
CD367145 Alveolar Macrophage, lung .b 1618 to 2301 700 to 17   AAA   684/684
(100 %)
0 diff
(100 %id)
CD365050 Alveolar Macrophage, lung .b 1619 to 2301 699 to 17   AAA   683/683
(100 %)
0 diff
(100 %id)
CB528766 Aveolar Macrophage, lung .b 1621 to 2301 697 to 17   AAA   681/681
(100 %)
0 diff
(100 %id)
BP306456   .b 1630 to 2202 1 to 573       573/573
(100 %)
0 diff
(100 %id)
CN480494 lung, Lung Focal Fibrosis .b 1630 to 2301 690 to 19   AAA   672/672
(100 %)
0 diff
(100 %id)
CA441717 Chondrosarcoma, Left Pubic Bone .b 1641 to 2301 677 to 17   AAA   661/661
(100 %)
0 diff
(100 %id)
BU742322 eye, fetal eye .b 1642 to 2301 676 to 17   AAA   660/660
(100 %)
2 diff
(99.7 %id)
CA307331 Alveolar Macrophage, lung .b 1642 to 2301 676 to 17   AAA   660/660
(100 %)
0 diff
(100 %id)
CD364332 Alveolar Macrophage, lung .b 1646 to 2301 672 to 17   AAA   656/660
(99 %)
2 diff
(99.7 %id)
CB529307 Aveolar Macrophage, lung .b 1646 to 2301 672 to 17   AAA   656/660
(99 %)
2 diff
(99.7 %id)
CN276973 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1657 to 2274 1 to 618       618/618
(100 %)
0 diff
(100 %id)
R73717 breast .b 1662 to 1872 1 to 211       211/211
(100 %)
0 diff
(100 %id)
BU730379 eye, RPE and Choroid .b 1680 to 2301 640 to 19   AAA   622/622
(100 %)
1 diff
(99.9 %id)
BI084793 epidermoid carcinoma, cell line, salivary gland .b 1694 to 2247 559 to 5   fully sequenced,   555/559
(99 %)
2 diff
(99.7 %id)
BU630186 cell lines, Chondrosarcoma .b 1705 to 2301 613 to 17   AAA   597/597
(100 %)
0 diff
(100 %id)
CB160586 Liver .b 1713 to 2208 1 to 496       496/496
(100 %)
0 diff
(100 %id)
AA379281 skin .b 1732 to 1992 1 to 261       261/261
(100 %)
0 diff
(100 %id)
BM128957 Islets of Langerhans, Pancreas .b 1739 to 2302 564 to 1   fully sequenced,   564/564
(100 %)
5 diff
(99.2 %id)
CA440569 lung, Lung Focal Fibrosis .b 1743 to 2301 577 to 19   AAA   559/559
(100 %)
0 diff
(100 %id)
AA358885 lung .b 1746 to 1994 1 to 249       249/249
(100 %)
0 diff
(100 %id)
CA427088 Bone, Subchondral Bone .b 1753 to 2301 567 to 19   AAA   549/555
(98 %)
1 diff
(99.9 %id)
AA150287 uterus .b 1755 to 2171 1 to 420       420/420
(100 %)
6 diff
(98.6 %id)
AW950204   .b 1759 to 2301 1 to 543   AAA   543/543
(100 %)
0 diff
(100 %id)
AI338177 lung .b 1806 to 2301 496 to 1       496/496
(100 %)
0 diff
(100 %id)
BG059688 brain, glioblastoma without EGFR amplification .b 1815 to 2299 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BM662510 eye, RPE and Choroid .b 1819 to 2301 498 to 16   fully sequenced, AAA   483/483
(100 %)
2 diff
(99.6 %id)
AL547317 placenta, Placenta Cot 25-normalized .b 1834 to 2299 1 to 466       466/466
(100 %)
0 diff
(100 %id)
AA148767 uterus .b 1841 to 2297 1 to 461   fully sequenced,   461/461
(100 %)
4 diff
(99.2 %id)
AA364158 pineal body .b 1842 to 2100 1 to 259       259/259
(100 %)
0 diff
(100 %id)
BM129444 Islets of Langerhans, Pancreas .b 1847 to 2302 456 to 1   fully sequenced,   456/456
(100 %)
0 diff
(100 %id)
AA476946 ovarian tumor, ovary .b 1851 to 2301 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
F27828 pectoral muscle (after mastectomy) .b 1860 to 2194 1 to 335       335/335
(100 %)
0 diff
(100 %id)
F37360 pectoral muscle (after mastectomy) .b 1860 to 2246 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BQ227883 epithelioid carcinoma, Pancreas .b 1883 to 2301 1 to 419   AAA   419/419
(100 %)
0 diff
(100 %id)
AI609066 ovary, tumor, 5 pooled (see description) .b 1905 to 2301 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AI720733 colon .b 1907 to 2299 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AA218698 brain, neuroepithelial cells .b 1909 to 2301 408 to 16   AAA   393/393
(100 %)
0 diff
(100 %id)
BX394405 Neuroblastoma Cot 25-normalized .b 1930 to 2303 1 to 374       374/374
(100 %)
0 diff
(100 %id)
AA418981 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1945 to 2296 1 to 352   fully sequenced,   352/352
(100 %)
0 diff
(100 %id)
BM782681 stomach .b 1964 to 2301 1 to 338   AAA   338/338
(100 %)
0 diff
(100 %id)
AI093495 uterus .b 1993 to 2301 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AA962595 pooled germ cell tumors .b 1997 to 2301 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AI185408 lung .b 2001 to 2302 302 to 1       302/302
(100 %)
0 diff
(100 %id)
CN276978 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2011 to 2301 2 to 292   AAA   291/292
(99 %)
6 diff
(98.0 %id)
EH342544   .b 2030 to 2100 1 to 71       71/71
(100 %)
0 diff
(100 %id)
BQ787736 insulinoma, Pancreas .b 2031 to 2306 278 to 1   fully sequenced,   278/278
(100 %)
5 diff
(98.3 %id)
BE018146 cervical carcinoma cell line, cervix .b 2032 to 2301 1 to 270   fully sequenced, AAA   270/270
(100 %)
0 diff
(100 %id)
AA150223 uterus .b 2036 to 2301 273 to 1   fully sequenced,   273/273
(100 %)
2 diff
(99.3 %id)
AA434317 ovarian tumor, ovary .b 2045 to 2280 1 to 237   fully sequenced,   237/237
(100 %)
2 diff
(99.2 %id)
AI871793 ovary, tumor, 5 pooled (see description) .b 2069 to 2301 233 to 1       233/233
(100 %)
0 diff
(100 %id)
AI741881 pooled .b 2072 to 2302 231 to 1       231/231
(100 %)
0 diff
(100 %id)
AA434106 ovarian tumor, ovary .b 2079 to 2298 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AA688306 normal prostate, Prostate .b 2080 to 2305 226 to 1       226/226
(100 %)
0 diff
(100 %id)
BY798977 eye .b 2087 to 2302 1 to 216       216/216
(100 %)
0 diff
(100 %id)
AI720557 colon .b 2093 to 2299 207 to 1       207/207
(100 %)
0 diff
(100 %id)
AA434229 ovarian tumor, ovary .b 2124 to 2298 175 to 1   fully sequenced,   175/175
(100 %)
0 diff
(100 %id)
AA418836 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2125 to 2304 180 to 1   fully sequenced,   180/180
(100 %)
1 diff
(99.5 %id)
BM144726 leukopheresis .b 2157 to 2299 159 to 17   AAA   143/144
(99 %)
7 diff
(95.2 %id)
BI962722 Islets of Langerhans, Pancreas .b 2159 to 2301 1 to 143   AAA   143/143
(100 %)
0 diff
(100 %id)
BE301628 cervical carcinoma cell line, cervix .b 2165 to 2302 138 to 1   fully sequenced,   138/138
(100 %)
0 diff
(100 %id)
AA558974 breast .b 2168 to 2301 169 to 36   AAA   134/134
(100 %)
0 diff
(100 %id)
AI922615 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2174 to 2301 128 to 1       128/128
(100 %)
0 diff
(100 %id)
AI682549 Prostate .b 2183 to 2301 119 to 1       119/119
(100 %)
0 diff
(100 %id)
AI971035 Prostate .b 2183 to 2301 119 to 1       119/119
(100 %)
0 diff
(100 %id)
AA456340 ovarian tumor, ovary .b 2188 to 2301 1 to 114   fully sequenced,   114/114
(100 %)
0 diff
(100 %id)
AA454693 ovarian tumor, ovary .b 2226 to 2294 69 to 1   fully sequenced,   69/69
(100 %)
0 diff
(100 %id)
BE463636 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 2232 to 2299 68 to 1       68/68
(100 %)
0 diff
(100 %id)
AI926212 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2238 to 2302 65 to 1       65/65
(100 %)
0 diff
(100 %id)
DB497980.
matches multiple genes
hypothalamus .c 1 to 499 1 to 499   tiling clone, also hits gene EPHA1 499/499
(100 %)
1 diff
(99.8 %id)
AK298925   .c 82 to 2131 1 to 2050   tiling clone,   2050/2050
(100 %)
0 diff
(100 %id)
DC367508   .c 82 to 555 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BC021039 Muscle, rhabdomyosarcoma .c 403 to 2131 899 to 2626   tiling clone, AAA   1728/2626
(65 %)
6 diff
(99.8 %id)
BC021069 Muscle, rhabdomyosarcoma .c 403 to 2131 899 to 2626   AAA   1728/2626
(65 %)
6 diff
(99.8 %id)
DC387088   .d 1 to 556 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
DC358012   .d 16 to 560 1 to 545       545/545
(100 %)
0 diff
(100 %id)
AK299005   .d 104 to 2123 1 to 2020 exact tiling clone,   2020/2020
(100 %)
2 diff
(100.0 %id)
DC368663   .d 104 to 686 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DC383628 Prostate .d 120 to 675 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DC319915 brain .d 122 to 627 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DC354694 lung .d 122 to 698 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
DC364242   .d 123 to 642 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BF343912 brain, glioblastoma with EGFR amplification .d 142 to 741 1 to 595       595/595
(100 %)
28 diff
(95.3 %id)
DC358071   .d 151 to 716 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC368563   .e 1 to 446 1 to 446   tiling clone,   446/446
(100 %)
0 diff
(100 %id)
AK316227   .e 97 to 1725 1 to 1629 exact tiling clone,   1629/1629
(100 %)
2 diff
(99.9 %id)
DC320380 brain .e 97 to 665 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC353543 brain .e 97 to 644 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
DC366651   .e 97 to 676 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
TI_57196271   .e 154 to 996 29 to 878       850/879
(96 %)
17 diff
(98.1 %id)
BP376020 uterus .e 158 to 711 1 to 554       554/560
(98 %)
1 diff
(99.9 %id)
CR975296 T-Lymphocytes .e 160 to 618 1 to 459       459/459
(100 %)
0 diff
(100 %id)
DA382942 thalamus .e 181 to 809 2 to 630   capped   629/629
(100 %)
1 diff
(99.9 %id)
BI020538 marrow .e 192 to 633 440 to 1       440/441
(99 %)
4 diff
(99.1 %id)
BI020599 marrow .e 193 to 503 311 to 2       310/311
(99 %)
0 diff
(100 %id)
BI020603 marrow .e 193 to 601 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
BI020607 marrow .e 193 to 512 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AI752696 Bone, Hip .e 228 to 666 8 to 446       439/446
(98 %)
6 diff
(98.7 %id)
TI_57215948   .e 239 to 1017 61 to 832       772/832
(92 %)
13 diff
(98.5 %id)
DA476557   .e 244 to 813 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI754563 brain .e 246 to 1017 1 to 765       765/765
(100 %)
9 diff
(98.9 %id)
BM009144 amelanotic melanoma, cell line, skin .e 258 to 1091 1 to 840       840/846
(99 %)
25 diff
(97.1 %id)
TI_59383859   .e 259 to 1091 63 to 901       839/845
(99 %)
24 diff
(97.2 %id)
TI_59384652   .e 259 to 972 62 to 783       722/807
(89 %)
41 diff
(95.0 %id)
BM558992 amelanotic melanoma, cell line, skin .e 261 to 1148 1 to 894       894/952
(93 %)
17 diff
(98.3 %id)
BM562073 amelanotic melanoma, cell line, skin .e 261 to 952 1 to 702       702/1126
(62 %)
14 diff
(98.8 %id)
BM423807 amelanotic melanoma, cell line, skin .e 261 to 1231 1 to 978       978/1084
(90 %)
21 diff
(98.1 %id)
BM811312 amelanotic melanoma, cell line, skin .e 262 to 1065 1 to 818       818/1139
(71 %)
26 diff
(97.8 %id)
DA708964   .e 265 to 818 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA847169 placenta .e 265 to 790 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
CX786463 human embryonic stem cells .e 269 to 954 1 to 686       686/686
(100 %)
0 diff
(100 %id)
DA915053   .e 282 to 835 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA696141   .e 283 to 834 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA541198 lung .e 287 to 879 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
BM791256 stomach .e 290 to 989 1 to 700       700/700
(100 %)
0 diff
(100 %id)
TI_154138216   .e 319 to 902 78 to 662       585/587
(99 %)
25 diff
(95.8 %id)
CN276979 embryonic stem cells, cell lines H1, H7, andH9 .e 331 to 843 1 to 513       513/513
(100 %)
0 diff
(100 %id)
DA967505 stomach .e 348 to 907 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
ES314891 occipital scalp hair, skin .e 353 to 512 9 to 167       159/167
(95 %)
7 diff
(95.9 %id)
ES314894 occipital scalp hair, skin .e 353 to 560 9 to 215       207/215
(96 %)
9 diff
(95.9 %id)
BI917486 brain .e 353 to 1122 38 to 810       771/812
(94 %)
21 diff
(97.5 %id)
TI_43961121   .e 353 to 1117 94 to 862       769/862
(89 %)
16 diff
(98.2 %id)
TI_57244856   .e 353 to 1122 66 to 838       771/840
(91 %)
21 diff
(97.5 %id)
ES314882 occipital scalp hair, skin .e 359 to 540 1 to 183       183/183
(100 %)
3 diff
(98.4 %id)
BF339051 brain, glioblastoma with EGFR amplification .e 359 to 1026 26 to 691       666/737
(90 %)
14 diff
(98.2 %id)
BP294788   .e 369 to 972 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
BG178332 adenocarcinoma, cell line, Prostate .e 370 to 1087 1 to 711       711/965
(73 %)
18 diff
(98.2 %id)
DA016605 adrenal gland .e 377 to 946 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP267431 thyroid .e 388 to 969 1 to 582       582/582
(100 %)
0 diff
(100 %id)
ES308664 beard hair, skin .e 391 to 565 1 to 176       176/176
(100 %)
3 diff
(98.3 %id)
BF738895 bladder_tumor .e 399 to 629 5 to 231       227/232
(97 %)
18 diff
(92.3 %id)
DB000103 breast, tumor tissue .e 399 to 941 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BP254592 Kidney .e 402 to 833 1 to 432       432/432
(100 %)
3 diff
(99.4 %id)
BE925432 amnion_normal .e 407 to 877 13 to 483       471/483
(97 %)
10 diff
(98.0 %id)
BF899346 marrow .e 414 to 735 329 to 7     Submitted on the opposite strand 323/329
(98 %)
0 diff
(100 %id)
BF901048 marrow .e 414 to 554 141 to 2     Submitted on the opposite strand 140/141
(99 %)
0 diff
(100 %id)
BF902087 marrow .e 414 to 732 330 to 13     Submitted on the opposite strand 318/330
(96 %)
0 diff
(100 %id)
TI_57244220   .e 420 to 1123 96 to 800       705/800
(88 %)
7 diff
(99.2 %id)
BI915261 brain .e 423 to 1123 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
AW074189 2 pooled high-grade transitional celltumors, genitourinary tract .e 434 to 876 460 to 18       443/461
(96 %)
2 diff
(99.6 %id)
AA310084   .e 436 to 781 1 to 346       346/346
(100 %)
0 diff
(100 %id)
TI_57219713   .e 453 to 1385 65 to 1005       941/1005
(93 %)
28 diff
(97.3 %id)
BI752889 brain .e 455 to 1385 1 to 939       939/939
(100 %)
25 diff
(97.4 %id)
BI825951 brain, medulla .e 456 to 1290 1 to 836       836/836
(100 %)
4 diff
(99.6 %id)
TI_57173793   .e 456 to 1290 31 to 866       836/866
(96 %)
9 diff
(99.0 %id)
AW401597 lymph .e 472 to 956 8 to 492       485/492
(98 %)
6 diff
(98.8 %id)
TI_154137695   .e 472 to 1088 77 to 692       616/846
(72 %)
15 diff
(98.3 %id)
BP325175 Pancreas .e 489 to 1068 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP252780 Kidney .e 490 to 1075 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BP299480   .e 490 to 1072 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP303328   .e 504 to 1085 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BI029087 marrow .e 505 to 1090 1 to 586       586/587
(99 %)
4 diff
(99.4 %id)
BP300755   .e 528 to 1107 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BG681267 skin, squamous cell carcinoma .e 554 to 1374 1 to 818       818/821
(99 %)
12 diff
(98.6 %id)
BF974185 B-cells, primary B-cells from tonsils (cell line) .e 563 to 1324 1 to 761       761/771
(98 %)
9 diff
(98.9 %id)
AA311960   .e 571 to 1047 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BP203108 coronary artery .e 589 to 1170 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM802362 duodenal adenocarcinoma, cell line, small intestine .e 590 to 1428 1 to 847       847/933
(90 %)
15 diff
(98.4 %id)
BI830598 brain, medulla .e 599 to 1546 1 to 956       956/1006
(95 %)
36 diff
(96.5 %id)
TI_57171144   .e 599 to 1546 33 to 988       956/1038
(92 %)
41 diff
(96.1 %id)
BM050152 epithelioid carcinoma cell line, Pancreas .e 601 to 1275 1 to 680       679/680
(99 %)
10 diff
(98.6 %id)
BP303696   .e 612 to 1180 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BE146092 head_neck .e 656 to 1103 462 to 15     Submitted on the opposite strand 448/471
(95 %)
5 diff
(99.0 %id)
BE733203 choriocarcinoma, placenta .e 660 to 1415 1 to 745       745/918
(81 %)
21 diff
(97.8 %id)
CX755500 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 670 to 1428 1 to 759     Submitted on the opposite strand 759/760
(99 %)
3 diff
(99.7 %id)
BM045415 carcinoma, cell line, Prostate .e 688 to 1566 1 to 886       886/894
(99 %)
21 diff
(97.7 %id)
CD617119   .e 704 to 1197 510 to 15       496/510
(97 %)
4 diff
(99.3 %id)
BI160767 epithelioid carcinoma cell line, Pancreas .e 721 to 1566 1 to 851       851/885
(96 %)
31 diff
(96.5 %id)
AA355253   .e 725 to 992 1 to 268       268/268
(100 %)
0 diff
(100 %id)
BG424853 Kidney, renal cell adenocarcinoma .e 740 to 1440 1 to 694       694/803
(86 %)
15 diff
(98.2 %id)
BG252081 adenocarcinoma, cell line, Liver .e 743 to 1445 1 to 700       700/977
(71 %)
12 diff
(98.8 %id)
BP304632   .e 749 to 1317 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BI029439 marrow .e 750 to 1090 348 to 8       341/348
(97 %)
1 diff
(99.8 %id)
CB216945 normal endometrium, mid-secretory phase,cycle day 23, uterus .e 756 to 1394 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BP297974   .e 759 to 1338 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BU158993 large cell carcinoma, lung .e 770 to 1561 1 to 792       792/847
(93 %)
5 diff
(99.5 %id)
CX784983 human embryonic stem cells .e 776 to 1405 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
BF724176 eye, Iris .e 779 to 1314 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BG119610 adenocarcinoma, cell line, Liver .e 781 to 1537 1 to 742       746/955
(78 %)
29 diff
(97.0 %id)
BG419488 Kidney, renal cell adenocarcinoma .e 782 to 1440 1 to 655       655/926
(70 %)
6 diff
(99.4 %id)
BF981524 duodenal adenocarcinoma, cell line, small intestine .e 791 to 1561 12 to 790       779/878
(88 %)
34 diff
(96.2 %id)
BG677621 skin, squamous cell carcinoma .e 809 to 1566 1 to 764       764/987
(77 %)
16 diff
(98.4 %id)
BG179365 adenocarcinoma, cell line, Prostate .e 814 to 1561 1 to 748       748/1117
(66 %)
17 diff
(98.5 %id)
CN276981 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 828 to 1495 1 to 668       668/668
(100 %)
0 diff
(100 %id)
CV810726 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 829 to 1559 1 to 729       729/880
(82 %)
24 diff
(97.3 %id)
BF339341 brain, glioblastoma with EGFR amplification .e 838 to 1556 1 to 718       718/718
(100 %)
12 diff
(98.4 %id)
BG282814 adenocarcinoma, cell line, Prostate .e 838 to 1557 1 to 717   tiling clone,   715/852
(83 %)
17 diff
(98.1 %id)
BM542950 embryonal carcinoma, cell line, testis .e 843 to 1440 1 to 600       600/1131
(53 %)
4 diff
(99.7 %id)
CB216251 normal endometrium, mid-secretory phase,cycle day 23, uterus .e 843 to 1451 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CN276983 embryonic stem cells, DMSO-treated H9 cellline .e 869 to 1465 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
AA218699 brain, neuroepithelial cells .e 876 to 954 1 to 79       79/79
(100 %)
3 diff
(96.3 %id)
BM796370 stomach .e 916 to 1345 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BX280111 ovary (pool of 3) .e 921 to 1429 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BF827230 head_normal .e 1005 to 1552 550 to 4     Submitted on the opposite strand 547/550
(99 %)
1 diff
(99.9 %id)
ES312416 frontal balding hair, skin .e 1061 to 1273 1 to 213       213/213
(100 %)
0 diff
(100 %id)
BF874706 lung_tumor .e 1099 to 1316 239 to 19     Submitted on the opposite strand 221/244
(90 %)
3 diff
(98.8 %id)
BI008641 kidney_tumor .e 1178 to 1477 312 to 8       305/313
(97 %)
11 diff
(96.5 %id)
BI008626 kidney_tumor .e 1229 to 1473 260 to 14       247/261
(94 %)
10 diff
(96.2 %id)
BF928123 nervous_tumor .e 1243 to 1531 303 to 15     Submitted on the opposite strand 289/321
(90 %)
4 diff
(98.8 %id)
FN070070 breast carcinoma .e 1510 to 1561 1 to 53       53/55
(96 %)
2 diff
(96.4 %id)
DC368001   .f 1 to 533 1 to 532   tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
DA136133 alzheimer cortex .f 459 to 1089 2 to 632   tiling clone, capped   631/631
(100 %)
0 diff
(100 %id)
CR989943 T-Lymphocytes .g 1 to 828 1 to 827 R244X Q246X tiling clone,   827/827
(100 %)
1 diff
(99.9 %id)
DN997453 breast cancer, Mammary gland (cancer tissue) .h 1 to 576 11 to 586   tiling clone,   576/586
(98 %)
6 diff
(99.0 %id)
BM919994 pooled pancreas and spleen .h 185 to 1076 1 to 900       900/1011
(89 %)
14 diff
(98.7 %id)
DC299589   .h 476 to 1038 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BP299258   .h 484 to 1066 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC397697 testis .h 544 to 1129 1 to 586   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
BG007398 placenta_normal .h 575 to 934 362 to 3       360/362
(99 %)
8 diff
(97.8 %id)
CA395616 eye, RPE/choroid .h 592 to 1191 1 to 600       600/600
(100 %)
0 diff
(100 %id)
AA386162 Pancreas .h 608 to 780 1 to 173       173/173
(100 %)
0 diff
(100 %id)
BF971762 leiomyosarcoma cell line, uterus .h 629 to 1245 1 to 612       612/635
(96 %)
6 diff
(99.1 %id)
BP252433 Kidney .h 641 to 1215 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BQ067626 pooled brain, lung, testis .h 917 to 1812 1 to 909 G92X S116K L117S E118W G119R ... tiling clone,   909/1029
(88 %)
23 diff
(97.8 %id)
DC365914   .i 1 to 542 3 to 545 A2X tiling clone,   545/545
(100 %)
2 diff
(99.7 %id)
AV730044 hypothalamus .j-u 1 to 444 1 to 442 K133G A134L Y135S H136P P137A ... tiling clone,   442/450
(98 %)
2 diff
(99.6 %id)
DA008528 adipose .k 1 to 503 2 to 504 exact tiling clone, capped   503/503
(100 %)
0 diff
(100 %id)
AA078361 placenta .l-u 1 to 294 1 to 294   tiling clone,   294/294
(100 %)
0 diff
(100 %id)
G30902   .l-u 1 to 294 1 to 294       294/294
(100 %)
0 diff
(100 %id)
BF893081 marrow .l-u 227 to 650 422 to 1   tiling clone, Submitted on the opposite strand 422/422
(100 %)
0 diff
(100 %id)
ES314531 occipital scalp hair, skin .l-u 442 to 626 1 to 184   tiling clone,   184/184
(100 %)
1 diff
(99.5 %id)
BG831833 epithelioid carcinoma cell line, Pancreas .m 1 to 415 1 to 418 P86A G87E R88D L89F S90P ... tiling clone,   418/418
(100 %)
6 diff
(98.6 %id)
BM724009 eye, fetal eye .n-u 1 to 657 1 to 655   tiling clone, fully sequenced,   655/655
(100 %)
1 diff
(99.9 %id)
CN483500 eye .n-u 159 to 730 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BE840177 prostate_normal .n-u 322 to 829 27 to 534       508/539
(94 %)
11 diff
(98.0 %id)
BI058930 placenta_normal .n-u 402 to 898 22 to 524       503/524
(95 %)
6 diff
(98.9 %id)
CN290082 embryonic stem cells, DMSO-treated H9 cellline .n-u 404 to 597 1 to 194       194/194
(100 %)
3 diff
(98.5 %id)
BF856367 prostate_normal .n-u 547 to 802 1 to 256       256/256
(100 %)
5 diff
(98.1 %id)
R71743 breast .n-u 558 to 881 1 to 329   fully sequenced,   329/329
(100 %)
3 diff
(99.1 %id)
BU742053 eye, fetal eye .n-u 627 to 1181 573 to 19 S44F tiling clone, fully sequenced, AAA   555/555
(100 %)
1 diff
(99.9 %id)
AA054668 uterus .n-u 637 to 894 1 to 261   fully sequenced,   261/261
(100 %)
2 diff
(99.3 %id)
R71744 breast .n-u 851 to 1183 339 to 1   tiling clone, fully sequenced,   339/339
(100 %)
6 diff
(98.3 %id)
AA054721 uterus .n-u 864 to 1183 341 to 14   tiling clone, fully sequenced, AAA   328/328
(100 %)
4 diff
(98.8 %id)
CV325850 marrow .o 1 to 415 1 to 419   tiling clone,   419/419
(100 %)
11 diff
(97.4 %id)
BX488476   .o 222 to 505 1 to 285   tiling clone,   285/285
(100 %)
1 diff
(99.7 %id)
H77286   .o 362 to 674 1 to 313   tiling clone,   313/313
(100 %)
1 diff
(99.7 %id)
DA177623 amygdala .o 537 to 1095 2 to 560 exact tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
AW363971 colon .o 697 to 1013 327 to 11       317/330
(96 %)
1 diff
(99.7 %id)
BF813051 colon_ins .p-u 1 to 319 5 to 323 G6S tiling clone,   319/329
(96 %)
6 diff
(98.2 %id)
BF908434 uterus_tumor .p-u 8 to 195 1 to 189   tiling clone,   189/190
(99 %)
3 diff
(98.5 %id)
BF910609 uterus_tumor .p-u 8 to 192 188 to 4   tiling clone, Submitted on the opposite strand 185/188
(98 %)
0 diff
(100 %id)
275 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l-u, .m, .n-u, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI